期刊文献+

阿维A、多烯磷脂酰胆碱联合中药熏蒸治疗寻常型银屑病疗效观察 被引量:4

Observation of Acitretin,Polyene Phosphatidylcholine with Chinese Medicine Fumigation on Psoriasis Vulgaris
下载PDF
导出
摘要 目的:观察阿维A、多烯磷脂酰胆碱联合中药熏蒸治疗方案对寻常型银屑病的疗效.方法:将50例患者随机分为两组,各25例.治疗组采用口服阿维A 20 ~40 mg/天,静滴多烯磷脂酰胆碱治疗,并联合中药熏蒸治疗;对照组仅口服阿维A治疗.两组患者均外用醋酸曲安奈德尿素乳膏,疗程均为4周.结果:治疗组、对照组有效率分别为88%和56%,差异有显著性(P<0.05).结论:阿维A、多烯磷脂酰胆碱联合中药熏蒸治疗方案对寻常型银屑效果好,不良反应少. Objection: To observe the effect of acitretin, polyene phosphatidylcholine with Chinese medicine fumigation on psoriasis vulgaris. Methods : 50 cases of patients were randomly divided into two groups, 25 cases in each group . The treatment group was treated with acitretin orally (20 -40 mg/d), polyene phosphatidylcholine infusion and Chinese medicine fumigation; the control group was given only acitretin orally. Topical triamcinolone acetonide acetate and urea cream was applied to all patients in two groups. The duration of therapy was four weeks. Results: The response rate of the treatment group and control group was 84% and 56% respectively, the difference was significance(P 〈0.05). Conclusion: The treatment of acitretin, polyene phosphatidylcholine with Chinese medicine fumigation on psoriasis vulgaris showed a beneficial effect.
出处 《山西中医》 2015年第8期10-11,共2页 Shanxi Journal of Traditional Chinese Medicine
关键词 银屑病 阿维A 多烯磷脂酰胆碱 中药熏蒸疗法 中西医结合疗法 psoriasis, acitretin, polyene phosphatidylcholine, Chinese medicine fumigation, integrative thera-py combined TCM with western medicine
  • 相关文献

参考文献7

二级参考文献27

  • 1杨洪浦,吕兵波,蒋俊青,毛舒和.中药熏蒸治疗银屑病[J].中国麻风皮肤病杂志,2006,22(1):41-42. 被引量:17
  • 2Glade CP, van Erp PE, Boezeman JB, et al. Multiparameter flow eytometry as a tool to evaluate antipsoriatic therapy[J]. Br J Dermatol, 1997, 137(3):367-375.
  • 3Piskin G, Heydendael VM, de Rie MA, et al. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ[J]. Arch Dermatol Res, 2003, 294(12): 559-562.
  • 4de Rie MA, Hamerlinck F, Hintzen RQ, et al. Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis[J]. Arch Dermatol Res, 1991, 283(8): 533-534.
  • 5Borska L, Andrys C, Krejsek J, et al. Serum levels of the pro-inflammatory cytokine interleukin-12 and the antiinflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen[J]. Int J Dermatol, 2008, 47(8):800-805.
  • 6Garduno J, Bhosle M J, Balkrishnan R, et al. Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review[J]. J Dermatolog Treat, 2007, 18(4):223-242.
  • 7Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid[J]. Dermatologica, 1978, 157(4): 238-244.
  • 8Krueger GG, Feldman SR, Camisa C, et al. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?[J]. J Am Acad Dermatol, 2000, 43(2 Pt 1):281-285.
  • 9Feldman SR, Fleischer AB Jr, Reboussin DM, et al. The self-administered psoriasis area and severity index is valid and reliable[J]. J Invest Dermatol, 1996, 106(1): 183-186.
  • 10Finlay AY, Khan GK, Luscombe DK, et al. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis[J]. Br J Dermatol, 1990, 123(6): 751-756.

共引文献81

同被引文献52

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部